Aim: Studies of the α7-type neuronal nicotinic acetylcholine receptor (AChR), one of the receptor forms involved in many physiologically relevant processes in the central nervous system, have been hampered by the inability of this homomeric protein to assemble in most heterologous expression systems. In a recent study, it was shown that the chaperone Ric-3 is necessary for the maturation and functional expression of α7-type AChRs [1] . The current work aims at obtaining and characterizing a cell line with high functional expression of the human α7 AChR. Methods: Ric-3 cDNA was incorporated into SHE-P1-hα7 cells expressing the α7-type AChR. Functional studies were undertaken using single-channel patch-clamp recordings. Equilibrium and kinetic [
Introduction
Nicotinic acetylcholine receptors (AChRs) participate in many cellular and physiological processes. They are members of the Cys-loop family of neurotransmitter-gated ion channels, all of which are pentameric transmembrane receptors [2] . AChRs are expressed in both the central and peripheral nervous systems (the neuromuscular junction and the electromotor synapse of electric fish). The homomeric α7 AChR is one of the most abundant AChR subtypes in the mammalian central nervous system [3] . Of the entire central nervous system, it is the hippocampus -the area of the brain involved in various aspects of learning and memory -that exhibits the highest levels of α7 AChR protein. The α7 AChR can act presynaptically, postsynaptically and perisynaptically to facilitate the liberation of neurotransmitters, mediate synaptic transmission [4] or modulate connections with different neurons by activating diverse second messenger routes. It is believed that these functions are carried out largely as a consequence of their high permeability to calcium [5] , since the entry of Ca 2+ facilitates the liberation of neurotransmitters.
The α7 AChRs are related to various diseases such as Alzheimer's, schizophrenia, certain types of epilepsy and Parkinson's disease [6] . Complete characterization of the kinetic and pharmacological properties of α7 AChRs is key both to understanding the physiopathological mechanisms operating in these diseases and to opening new avenues for developing therapeutic intervention.
The α7 AChR has proved very difficult to express in mammalian cells. Although there have been reports on the expression of α7 AChR in various of these cells [7, 8] , functional receptors have been very hard to obtain in practically all the cell lines studied to date [9] [10] [11] [12] . Previous reports indicated that the Ric-3 protein is necessary to produce detectable levels of α7 AChRs at the cell surface. Ric-3, first discovered in Caenorhabditis elegans, is an endoplasmic reticulum-resident protein present in cells that endogenously express α7 AChR [13] . Ric-3 has been shown to increase α7 AChR heterologous expression in oocytes from Xenopus laevis and in mammalian cell lines such as HEK-293 [13] [14] [15] [16] [17] . According to these authors, Ric-3 is needed to attain the correct folding of the α7 AChR, and therefore to attain functional expression. Furthermore, William et al [13] contend that Ric-3 does not increase the transport of α7 AChR from the ER to the cell surface membrane; rather, it facilitates the correct assembly at the ER, thereby increasing the expression of functional cell-surface AChRs. They further argue that in the absence of Ric-3, palmitoylation of α7 AChRs would not occur, thus preventing functional heterologous expression of these receptors in HEK-293 cells. It is worth mentioning that other proteins are also palmitoylated in this type of cell. In 2004, Drisdel et al [15] proposed that the role of Ric-3 fits the definition of a specific chaperone that renders cysteine residues of α7 subunits accessible to palmitoylation in the ER, since cells that do express functional α7 AChR in their plasma membrane, such as PC12 cells and oocytes, express Ric-3 endogenously [13, 15] . Most studies indicate that Ric-3 does not remain associated with assembled AChRs at the cell surface [1] . The low levels of cell-surface expression have limited our understanding of the kinetic activation of α7 AChRs. Few studies have reported single-channel currents in oocytes from wild-type and mutant α7 AChRs [18, 19] . Recently, the human α7 AChR and the Ric-3 protein were transiently transfected in BOSC 23 cells [20] . Furthermore, Roncarati et al [21] produced a CHO-derived cell line that stably expresses α7 AChRs with the aid of the Ric-3 chaperone.
Although the neuroepithelial cell line SHE-P1-hα7 expresses α7 AChRs in a stable manner [8] , the levels of surface expression are so low that the receptor protein cannot be detected by conventional fluorescence microscopy or electrophysiological techniques. In the present report, SHE-P1-hα7 cells are shown to display robust α7 AChR expression at the cell membrane upon transient transfection with Ric-3 cDNA. In addition, a novel cell line was obtained (SHE-P1-hα7-Ric-3) that stably expresses functional α7 AChRs at the cell surface by co-transfection of the Ric-3 protein, thus opening new possibilities for characterizing the α7 AChR in mammalian cells.
Materials and methods
Cell culture, plasmid construction and production of the novel cell line SHE-P1-hα7 cells [22] were cultured in DMEM supplemented with 5% fetal bovine serum, 10% horse serum and Hygromycin B in a Napco 6100 incubator at 37 °C with 5% CO 2 . The new clone, SHE-P1-hα7-Ric-3, was obtained by transfection of Ric-3 cDNA (kindly provided by Prof M CRIADO, Instituto de Neurociencias de Alicante, Universidad Miguel Hernández, Alicante, Spain) into SHE-P1-hα7 cells [22] using FuGENE 6 (Roche, Indianapolis). Selection of positive clones was performed 48 h later by incubating the cells with G418 (400 mg/L). Every two days the cell culture medium was changed to remove dead cells. A novel cell line was produced that expressed both α7 AChR and the Ric-3 protein in a stable manner. SHE-P1-hα7-Ric-3 cells were subsequently cultured in DMEM supplemented with G418 (40 mg/L) and Hygromycin B with 5% fetal bovine serum, 10% horse serum and Hygromycin B as above. GFP-α7 was constructed by subcloning into the Sal/BamHI sites of pEGFP-N2 (Clontech, Palo Alto, CA) in Prof Criado's laboratory (Instituto de Neurociencias de Alicante, Universidad Miguel Hernández, Alicante, Spain). Ric-3 cDNA was subcloned into the XhoI/EcoRI sites of pEGFP-N1 (Clontech, Palo Alto, CA) at the Instituto de Neurociencias in Alicante.
Patch-Clamp recordings Single-channel currents were recorded in the cell-attached configuration at membrane potentials of -70, +50, and +70 mV at 20 °C using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Inc, CA), digitized at 94 kHz with an ITC-16 interface (Instrutech Corporation, Long Island, NY) and transferred to a computer using Acquire software (Bruxton Corporation, Seattle, WA). The bath and pipette solutions contained 142 mmol/L KCl, 5.4 mmol/L NaCl, 1.8 mol/L CaCl 2 , 1.7 mmol/L MgCl 2 and 10 mmol/L HEPES (pH 7.4). Patch pipettes were pulled from Kimax-51 capillary tubes (Kimble Products, Vineland, NJ), coated with Coat D (M-Line accessories, Measurements Group, Raleigh, NC), and firepolished. Pipette resistances ranged from 5 to 7 MΩ. ACh working solutions (50 μmol/L) were dissolved in the bath solution and applied to the cell through the patch pipette tip. Detection of single-channel events using the program TAC followed the half-amplitude threshold criterion (Bruxton Corporation, Seattle, WA) at a bandwidth of 5 kHz. The sampling time was 20 μs and the minimum detectable interval was 0.066 ms. Open, burst and closed-time histograms were plotted using a logarithmic abscissa and a square root ordinate. They were then fitted to the sum of exponential functions by the maximum likelihood criterion using the TACFit program (Bruxton Corporation, Seattle, WA). Burst resolution was obtained from the intersection between the main closed-time component and the succeeding one.
Fluorescence microscopy Cells were grown on 25 mm diameter glass coverslips in DMEM for 2-3 days at 37 °C. Overexpression of GFP-α7 in SHE-P1-hα7 cells was carried out using Lipofectamine 24 h after cell plating following the protocol provided by the manufacturer (Gibco BRL, Life Technologies, Buenos Aires). Cells were visualized 48 h later.
Wide-field fluorescence microscopy Imaging was carried out using a Nikon Eclipse E-600 microscope equipped with 40X NA 1.0 or 100X NA 1.4 objectives, digitized with a model ST-7 SBIG digital charge-coupled device camera (765×510 pixel, 9.0×9.0 mm pixel size; Santa Barbara, CA), and thermostatically cooled at -10 °C. The ST-7 CCD camera was driven by the CCDOPS software package (SBIG Astronomical Instruments, version 5.02). Appropriate excitation, dichroic and emission filters were employed to avoid crossover of fluorescence emission following previously established conditions [32, 33] . Sixteen-bit TIFF images were exported for further offline analysis.
Confocal microscopy Images were obtained with a [23] Data analysis Data are expressed as mean±SD from independent experiments. Statistical analysis was performed using Student's t-test. A value of P≤0.05 was considered statistically significant.
Results
Native α7 AChR expression in SHE-P1-hα7 cells The human epithelial cell line SHE-P1 [24] shares a common neuroepithelial ancestry with neurons. SHE-P1 cells that stably express human α7 AChRs (SHE-P1-hα7) but lack other subtypes of nicotinic receptors have been produced, and some of the pharmacological properties of this cell line have been characterized [8] . The mRNA products of SHE-P1-null (the parental cell line) and SHE-P1-hα7 cells after RT-PCR are shown in Supplementary Figure 1 ; only SHE-P1-hα7 cells express mRNA for the α7 subunit. In accordance with previous observations, α7 AChR protein expression is restricted to the intracellular compartment, despite the presence of α7 mRNA elsewhere ( Figure 1B) . Confocal microscopy of intact, non-permeabilized SHE-P1-hα7 cells stained with Alexa 488 αBTX revealed that the protein is absent from the cell ( Figure 1A) . In order to estimate the level of α7 AChR expression, radioligand binding studies were carried out in parallel using [ 125 I]αBTX. Figure 1C compares the levels of total and cellsurface pools of [
125 I]αBTX binding sites in SHE-P1-hα7 cells. Less than 1% of the total α7 AChRs is expressed at the cell surface in SHE-P1-hα7 under normal conditions ( Figure   1C ).
Next, we sought to enhance the level of α7 AChR expres- sion at the cell surface. In an initial series of experiments, cells were re-transfected with α7 subunit cDNA and incubated for 48 h in the presence of nicotine or at a lower temperature (25 o C, as in ref [22] for the same period). The level of expression of α7 AChRs at the cell surface of SHE-P1-hα7 could still not be detected by conventional wide-field fluorescence microscopy or by electrophysiological techniques at the single-channel level (data not shown), indicating that enhancing the levels of plasmid DNA is not sufficient to increase cell-surface expression.
Heterologous expression of Ric-3 establishes a robust cell-surface expression of α7 AChR Given the successful use of the chaperone protein Ric-3 on α7 AChR expression in heterologous systems [1] , SHE-P1-hα7 cells were transiently transfected with human Ric-3 (see Materials and methods) and α7 AChR expression was evaluated by fluorescent αBTX binding (Supplementary Figure 2) . It became apparent that α7 AChR cell-surface expression increased remarkably upon co-expression of Ric-3 when compared with that of SHE-P1-hα7 cells not transfected with the chaperone protein.
This finding led us to attempt to express both proteins, Ric-3 and α7 AChR, in a stable manner. For this purpose, SHE-P1-hα7 cells with a constitutively expressed α7 gene (Hygromycin B selection) were transfected with human Ric-3, and maintained in culture with G418 selection medium (see Materials and methods). Positive clones were subsequently selected. Cell-surface expression in one such clone, coined SHE-P1-hα7-Ric-3, was assessed by αBTX binding using Alexa 594 αBTX or anti-α7 monoclonal antibodies. The surface pool of α7 AChRs in intact, living SHE-P1-hα7-Ric-3 cells displayed a finely punctate distribution all along the cell surface when stained with Alexa 594 αBTX ( Figure 1D ) or anti-α7 monoclonal antibodies followed by the Alexa 594 secondary antibody ( Figure 1E ). "Hot spots" were also observed (arrows) with the monovalent ligand (the fluorescent αBTX). It should be noted that cells were examined 15 min after exposure to [ 125 I]αBTX or Alexa-labeled αBTXs. This relatively brief incubation with the toxin was chosen after determining the optimal AChR rendering at the plasmalemma (5-120 min). Longer periods of incubation (>15 min) already showed a considerable degree of AChR internalization (Supplementary Figure 3) . The results of the fluorescence microscopy experiments were corroborated by bly expressed ( Figure 1F ).
The enhanced expression was restricted to the transiently expressed GFP-α7 . Figure 2 shows wide-field microscopy images of these cells 48 h after transfection. GFP-α7 was also found at the cell membrane, co-localizing with Alexa 555 αBTX staining. Interestingly, in addition to the predominantly finely punctate and spotty distribution observed with fluorescent bungarotoxin-stained α7 AChRs at the cell surface (single arrows, red staining), larger aggregates of GFP-labeled α7 AChRs (green) were observed (Figure 2 , circles) that colocalized (Figure 2 , merge) with larger clusters of presumably constitutively expressed AChRs tagged with Alexa 555 αBTX. Another form of cell-surface receptor aggregates was also observed in ~55% of the cells: several micron-sized "patches" (bracket) reminiscent of the large AChR clusters in developing myotubes [25] .
Equilibrium binding and kinetics of [
125 I]αBTX to SHE-P1-hα7-Ric-3 cells Next, we investigated the kinetics and equilibrium binding of [
125 I]αBTX in SHE-P1-hα7-Ric-3 cells (Figure 3 ). Cells were incubated for 15 min with increasing concentrations of [ 125 I]αBTX ( Figure 3A) . B max , the maximum number of binding sites, was estimated to be 233.2 fmol/mg protein and the apparent equilibrium binding constant, K D , 54.92±9.2 nmol/L ( Figure 3B) .
Studies of the association kinetics of [ 125 I]αBTX to the α7 AChR yielded a half-time of about7.0 min ( Figure 3C ). Linearization of the kinetic curves, obtained by plotting ln (Beq/Beq -Bt) as a function of time [26] , yielded an apparent k on value of 32.3±1.32 h -1 . The half-time for dissociation was calculated to be 20.0 min ( Figure 3D ).
Pharmacological properties of the α7 AChR in SHE-P1-hα7-Ric-3 cells Studies were conducted next to evaluate the pharmacological properties of the α7 AChR in SHE-P1-hα7-Ric-3 cells. To this end, we incubated the cells with increasing concentrations of nicotine for 10 min at room temperature prior to the application of 40 nmol/L [ 125 I]αBTX for an additional 15 min at 4 o C. As evidenced by the data presented in Figure 3E , nicotine competes with αBTX for the agonist/antagonist binding site. The calculated IC 50 for nicotine was about 40 µmol/L and the K i value was 23.26 µmol/L.
Functional properties of α7 AChR in SHE-P1-hα7-Ric-3 cells The functional properties of the α7 AChR expressed in SHE-P1-hα7-Ric-3 cells were studied using the patch-clamp technique. Single-channel currents were recorded from cells exposed to 50 µmol/L ACh at different membrane potentials ( Figure 4A ). The α7 AChR exhibited two main open-time durations at -70 mV, τ open1 =0.29±0.1 ms and τ open2 =0.67±0.03 ms, the former being the predominant component. At +50 mV, τ open1 lasted 0.12±0.02 ms and τ open2 =0.42±0.07 ms; their relative weight was about the same. Open-time durations at different membrane potentials are shown in Figure 4B .
Closed-time intervals exhibited two main components at positive potentials ( Figure 4C ). The first, τ close1 , most likely represents the transition of a channel that opens, closes and reopens. The second component, τ close2 , represents intervals between individual openings of a single channel. At negative membrane potentials, three closed-time components were observed. The third component possibly represents transitions to a desensitized AChR, which becomes more evident at negative membrane potentials ( Figure 4C) .
Two burst-time components were identified at all membrane potentials assayed ( Figure 4D ). At +50 mV and -70 mV, the first component lasted 0.29±0.15 ms and 0.26±0.13 ms, respectively, probably reflecting unitary apertures. The second component lasted 1.28±0.82 ms and 0.90±0.33 ms, respectively, indicating that some openings occurred in groups at 50 µmol/L ACh.
Finally, we evaluated the amplitudes of the currents generated by channel openings ( Figure 4E) . Histograms obtained at different membrane potentials revealed that there were two to three different levels of channel amplitudes (Amp 1 =6.92±2.86 pA, Amp 2 =12.53±1.43 pA, at -70 mV). Transient cell-surface expression of GFP-α7 in SHE-P1-hα7-Ric-3. Wide-field fluorescence microscopy of α7 AChR in SHE-P1-hα7-Ric-3 cells 48 h after transfection with GFP-α7. Constitutively expressed AChR predominantly shows a finely punctuate, spotty distribution at the cell surface (stained red with Alexa 555 αBTX) and larger clusters (single arrows) that co-localize (merged image) with the larger clusters of transiently expressed GFP-labeled AChR (green). Micron-sized patches (double arrows) are also apparent. Scale bar=30 µm (×1000).
Discussion
The neuronal α7 is the only mammalian subunit that appears to preferentially form homomeric, rather than heteromeric, receptors in heterologous expression systems [27] [28] [29] . Although α7 subunits form functional homomeric AChRs when expressed in Xenopus oocytes, they do so much less efficiently in many types of cultured cell lines [10] [11] [12] 30] . In comparison with several other transmembrane proteins, the assembly of ion channels, such as the AChR, is a slow and inefficient process. Each subunit must adopt the correct transmembrane topology and undergo critical post-translational modifications [31] . Proper conformational folding of the subunit is essential for the formation of fully assembled pentameric receptors. The early steps of receptor folding and assembly occur within the ER, the intracellular compartment containing several proteins required for efficient protein folding and post-translational modification [31] . There is evidence that AChR folding, assembly and trafficking are influenced by several chaperone proteins. Recent studies have shown that co-expression of α7 AChR and the chaperone RIC-3 facilitates the formation of functional homomeric AChRs in otherwise non-permissive cell types [13, 14, 16, 17] . RIC-3 was originally identified in the nematode Caenorhabditis elegans as a protein encoded by the gene ric-3 (resistance to inhibitors of cholinesterase) and has subsequently been cloned and characterized for mammalian and insect species. RIC-3 is required for efficient folding, assembly and functional expression of receptors and, unlike other chaperone proteins, appears to be highly specific in its chaperone activity. RIC-3 is a transmembrane ER-resident protein, with most studies indicating that it does not remain associated with assembled AChRs at the cell surface [1] . In this work, stable expression of the Ric-3 protein in SHE-P1-hα7 cells led to the production of a new cell line, SHE-P1-hα7-Ric-3, which exhibits robust α7 subunit cellsurface expression. The levels of cell-surface α7 AChRs in this new cell line increased from less than 1% to 20% (Figure 1). On the basis of previous reports [13, 14, 16, 17] , we can surmise that Ric-3 facilitates the correct folding and assembly of α7 subunits at the ER. When the parental SHE-P1-hα7 cells were labeled with fluorescent αBTX, a punctate distribution reminiscent of the ER staining was observed throughout the cell ( Figure 1B ). This localization of the receptor proteins is highly suggestive of retention and accumulation of unassembled receptors in the ER, as previously observed with Torpedo muscle AChRs expressed in mouse fibroblasts [31] or with adult muscle AChRs in CHO cells [32] . The association kinetics of αBTX to α7 AChRs in SHE-P1-hα7-Ric-3 cells is much faster (apparent k on =32.3±1.32 h -1 ) than for adult muscle-type AChRs expressed in CHO-K1/A5 cells [33] (k on =1.2±0.12 h -1
). The half-life of the α7 AChRs was also much shorter (~7 min) than that of adult muscle AChRs expressed in CHO-K1/A5 cells [34] (~5.0 h), BC3H-1 cells [34] (~7.7 h), or Q-A33 quail fibroblasts transfected with the adult AChR [35] (~9.8 h). The shorter half-life of the α7 AChRs at the cell membrane may be due to a lack of α7 AChRs at the cell membrane. Alternatively, this short half-life could be the result of a defective interaction between the α7 AChRs proteins needed for long-term receptor stability. Gu et al [36] suggested that the metabolic stability of the AChR arises from its association with other proteins that stabilize it, which are presumably absent from SHE-P1 cells. In our experiment, the dissociation constant K D for αBTX binding to the α7 AChR was rather high compared to previously published values [37, 38] . However, it was in agreement with the very short incubation times used in the radioligand and fluorescent binding assays. In addition, incubations with fluorescent αBTX for periods longer than 15 minutes resulted in the internalization of α7 AChRs (see Figure 3 , supplementary material). Furthermore, stably expressed α7 AChRs exhibited in vitro pharmacological properties typical of this type of AChR. Inhibition of [I 125 ]αBTX binding by nicotine displayed an IC 50 of ~40 nmol/L, in agreement with previous reports for mammalian cells in culture [39] . The calculated value for the K i was also similar to that which was previously reported [37] . As for the ion permeation properties of the stably expressed α7 AChR in the new SHE-P1-hα7-Ric-3 cell line, patch-clamp recordings showed single-channel currents when exposed to the natural agonist ACh. The observed kinetic parameters are compatible with those reported for α7 AChRs transiently expressed in oocytes [19] and in BOSC 23 cells [20] . A recent report [21] describing the functional properties of α7 AChRs heterologously expressed in CHO cells failed to observe receptor-mediated Ca 2+ fluxes when nicotinic agonists were used to activate the AChR in the absence of the positive allosteric modulator PNU-120596 or after pretreatment of cells with the tyrosine kinase inhibitor genistein.
The production of a stable cell line that expresses high levels of cell-surface receptors and exhibits channel activation with the natural agonist acetylcholine, as reported here, constitutes an important advancement in the study of neuronal α7-type homomeric receptors in mammalian cells.
